Marc Goodman

Stock Analyst at Leerink Partners

(2.67)
# 569
Out of 5,331 analysts
141
Total ratings
58.46%
Success rate
32.77%
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
OPT Opthea
Downgrades: Market Perform
12 1
n/a n/a 2 Mar 25, 2025
AXSM Axsome Therapeutics
Maintains: Outperform
110 150
112.17 33.73% 7 Feb 10, 2025
RLMD Relmada Therapeutics
Downgrades: Market Perform
10 1
0.36 177.78% 3 Dec 4, 2024
BHVN Biohaven
Maintains: Outperform
55 60
22.79 163.27% 6 Sep 23, 2024
LENZ LENZ Therapeutics
Initiates Coverage On: Outperform
32
29.66 7.89% 1 Apr 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Mar 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
63 -60.32% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 5 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
16.49 203.21% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 23
n/a n/a 4 Jan 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 20
12.09 65.43% 3 Jan 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 1
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
100 115
109.71 4.82% 4 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
270 310
123.38 151.26% 11 Oct 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 4
n/a n/a 4 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 12
8.69 38.09% 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 46
38.35 19.95% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
170 270
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 21
14.88 41.13% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 210
120.03 74.96% 5 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
50 40
7.27 450.21% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.72 481.4% 2 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
24 27
31.82 -15.15% 5 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
n/a n/a 3 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10 2
n/a n/a 4 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 15
2.79 437.63% 2 Dec 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 32
n/a n/a 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
322 70
n/a n/a 3 May 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
200 220
n/a n/a 1 Feb 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
300 270
395.91 -31.8% 5 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
79 96
198.44 -51.62% 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
189 203
n/a n/a 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
72 0
n/a n/a 2 May 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 7
n/a n/a 4 Nov 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 16
n/a n/a 2 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 67
83.05 -19.33% 3 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 15
n/a n/a 2 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
84 98
25.61 282.66% 3 Oct 5, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Mar 20, 2017